학술논문

Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN study
Document Type
Article
Source
In Blood 2 October 2014 124(14):2196-2202
Subject
Language
ISSN
0006-4971